Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:3191-3195
Published online before print May 17, 2004, doi: 10.1161/01.CIR.0000130590.24107.D3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/25/3191    most recent
01.CIR.0000130590.24107.D3v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campia, U.
Right arrow Articles by Panza, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campia, U.
Right arrow Articles by Panza, J. A.
Related Collections
Right arrow Risk Factors
Right arrow Clinical Studies
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2004;109:3191-3195.)
© 2004 American Heart Association, Inc.


Clinical Investigation and Reports

Ethnic Differences in the Vasoconstrictor Activity of Endogenous Endothelin-1 in Hypertensive Patients

Umberto Campia, MD; Carmine Cardillo, MD; Julio A. Panza, MD

From the National Heart, Lung, and Blood Institute, Bethesda, Md (U.C., C.C., J.A.P.); Università Cattolica del Sacro Cuore, Rome, Italy (C.C.); and Washington Hospital Center, Washington, DC (U.C., J.A.P.).

Correspondence to Dr Julio A. Panza, Washington Hospital Center, 110 Irving St, NW, Suite 2A 74, Washington, DC 20010. E-mail julio.a.panza{at}medstar.net

Received January 21, 2004; accepted March 13, 2004.

Background— The pathogenesis of essential hypertension in blacks may differ from that in whites. In particular, black patients usually present with a salt-sensitive, low-renin form, which in animal models is associated with enhanced activity of endothelin-1 (ET-1). This study aimed to assess whether ethnic differences exist in the vascular activity of ET-1 in normotensive and hypertensive blacks and whites.

Methods and Results— Forearm blood flow (FBF) responses to intraarterial infusion of an ETA receptor blocker (BQ-123) were analyzed by plethysmography in 37 normotensive patients and 27 hypertensive patients according to race. BQ-123 did not affect FBF in normotensive subjects (P=0.30), whereas it produced significant vasodilation in hypertensive subjects (P<0.001). In normotensives, FBF response to BQ-123 was similar in white (n =22) and black (n =15) patients (P=0.85). In contrast, in hypertensive patients, the vasodilator effect of ETA receptor blockade was significantly higher in blacks (n =13) than in whites (n =14) (P=0.01). To rule out differences in smooth muscle reactivity, the effects of race on FBF responses to exogenous ET-1 were analyzed in the hypertensive subgroups. Endothelin-1 induced a significant vasoconstriction in both white (n =7) and black patients (n =5) (both P<0.001), without differences between them (P=0.46). In 8 black hypertensives, the response to selective ETA blockade was not modified by nonselective blockade of ET-1 receptors by co-infusion of BQ-123 and BQ-788 (P=0.66).

Conclusions— Hypertensive blacks have enhanced ETA-dependent vasoconstrictor tone, probably related to increased production of ET-1. Given the negative vascular effects of ET-1, this abnormality may contribute to the pathogenesis of hypertension and its complications in black patients.


Key Words: hypertension • endothelin • endothelium




This article has been cited by other articles:


Home page
HypertensionHome page
D. H.J. Thijssen, E. A. Dawson, T. M. Tinken, N. T. Cable, and D. J. Green
Retrograde Flow and Shear Rate Acutely Impair Endothelial Function in Humans
Hypertension, June 1, 2009; 53(6): 986 - 992.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B. Battistini, N. Berthiaume, N. F. Kelland, D. J. Webb, and D. E. Kohan
Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel "-Sentan" Class of Drug.
Experimental Biology and Medicine, June 1, 2006; 231(6): 653 - 695.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Saha, G. J. Eckert, W. T. Ambrosius, T.-Y. Chun, M. A. Wagner, Q. Zhao, and J. H. Pratt
Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension
Hypertension, September 1, 2005; 46(3): 481 - 487.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. G. Warnock and P. D. Bell
Improvement of Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension
Hypertension, September 1, 2005; 46(3): 469 - 470.
[Full Text] [PDF]